OTC Markets EXMKT - Delayed Quote USD

Calithera Biosciences, Inc. (CALA)

Compare

0.0010

0.0000

(0.00%)

At close: October 22 at 1:56 PM EDT

Currency in USD All numbers in thousands

Download

Breakdown

TTM

12/31/2022

12/31/2021

12/31/2020

12/31/2019

Total Revenue

9,750.0000

Operating Expense

42,074.0000

74,308.0000

91,387.0000

92,895.0000

Operating Income

-42,074.0000

-64,558.0000

-91,387.0000

-92,895.0000

Net Non Operating Interest Income Expense

477.0000

345.0000

1,250.0000

3,035.0000

Other Income Expense

1,947.0000

-50,875.0000

Pretax Income

-39,650.0000

-115,088.0000

-90,137.0000

-89,860.0000

Net Income Common Stockholders

-21,290.0000

-115,088.0000

-90,137.0000

-89,860.0000

Average Dilution Earnings

-18,360.0000

Diluted NI Available to Com Stockholders

-39,650.0000

-115,088.0000

-90,137.0000

-89,860.0000

Basic EPS

-4.60

-31.16

-26.20

-38.00

Diluted EPS

-7.94

-31.16

-26.20

-38.00

Basic Average Shares

4,633.0000

3,693.0000

3,441.0000

2,365.6000

Diluted Average Shares

4,992.0000

3,693.0000

3,441.0000

2,365.6000

Total Operating Income as Reported

-42,074.0000

-115,433.0000

-91,387.0000

-92,895.0000

Total Expenses

42,074.0000

74,308.0000

91,387.0000

92,895.0000

Net Income from Continuing & Discontinued Operation

-39,650.0000

-115,088.0000

-90,137.0000

-89,860.0000

Normalized Income

-41,597.0000

-64,213.0000

-90,137.0000

-89,860.0000

Interest Income

477.0000

345.0000

1,250.0000

3,035.0000

Net Interest Income

477.0000

345.0000

1,250.0000

3,035.0000

EBIT

-42,074.0000

-64,558.0000

-91,387.0000

-92,895.0000

EBITDA

-41,819.0000

-64,278.0000

-91,023.0000

-92,416.0000

Reconciled Depreciation

255.0000

280.0000

364.0000

479.0000

Net Income from Continuing Operation Net Minority Interest

-39,650.0000

-115,088.0000

-90,137.0000

-89,860.0000

Total Unusual Items Excluding Goodwill

1,947.0000

-50,875.0000

Total Unusual Items

1,947.0000

-50,875.0000

Normalized EBITDA

-43,766.0000

-13,403.0000

-91,023.0000

-92,416.0000

12/31/2019 - 10/2/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

STAB Statera Biopharma, Inc.

0.0002

0.00%

PKBO Peak Bio, Inc.

0.0700

0.00%

CSLLY CSL Limited

99.10

-2.31%

GRTX Galera Therapeutics, Inc.

0.0553

-0.45%

BTTX Better Therapeutics, Inc.

0.0001

0.00%

OBIO Orchestra BioMed Holdings, Inc.

5.83

+7.76%

CRGX CARGO Therapeutics, Inc.

21.01

+0.24%

SEER Seer, Inc.

1.8600

-2.62%

ELOX Eloxx Pharmaceuticals, Inc.

0.0002

0.00%

DTIL Precision BioSciences, Inc.

8.78

-0.45%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Calithera Biosciences, Inc. (CALA)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers